Your browser doesn't support javascript.
loading
Selenomethionine and methyl selenocysteine: multiple-dose pharmacokinetics in selenium-replete men.
Marshall, James R; Burk, Raymond F; Payne Ondracek, Rochelle; Hill, Kristina E; Perloff, Marjorie; Davis, Warren; Pili, Roberto; George, Saby; Bergan, Raymond.
Affiliation
  • Marshall JR; Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
  • Burk RF; Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, C2104 Medical Center North, Nashville, TN 37232, USA.
  • Payne Ondracek R; Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
  • Hill KE; Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, C2104 Medical Center North, Nashville, TN 37232, USA.
  • Perloff M; National Cancer Institute, Bethesda, MD 20892, USA.
  • Davis W; Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
  • Pili R; Department of Medicine, Indiana University School of Medicine, R3 C516, Indianapolis, IN 46202, USA.
  • George S; Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
  • Bergan R; Knight Cancer Institute, Oregon Health Sciences University, Portland, OR 97239, USA.
Oncotarget ; 8(16): 26312-26322, 2017 Apr 18.
Article in En | MEDLINE | ID: mdl-28412747
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Selenomethionine / Selenocysteine / Dietary Supplements Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Language: En Journal: Oncotarget Year: 2017 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Selenomethionine / Selenocysteine / Dietary Supplements Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Language: En Journal: Oncotarget Year: 2017 Type: Article Affiliation country: United States